Nexvet Biopharma plc (NVET) has 12 open-market insider trades by 10 insiders since 2014. The most active filer is David Gearing, Chief Scientific Officer.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Robert Atchinson | 10% | — | 1 | $2.8M | 2014-02-10 |
| David T. Kim | 10% | — | 1 | $1.4M | 2016-02-26 |
| Funds Management Ltd Atf Asia Pacific Healthcare Fund One II | 10% | — | 1 | $1.0M | 2015-02-10 |
| David Gearing | Chief Scientific Officer | — | 2 | $140K | 2016-07-01 |
| Richard B. Fried | 10% | — | 1 | $72K | 2015-09-10 |
| Cormac G. Kilty | Dir | — | 2 | $57K | 2017-07-31 |
| George W. Gunn | Dir | — | 1 | $55K | 2017-07-31 |
| Damian T. Lismore | CFO | — | 1 | $16K | 2017-07-31 |
| Ashraf Hanna | Dir | — | 1 | $5K | 2017-07-31 |
| Geraldine T. Farrell | VP OperationsGeneral Counsel | — | 1 | $432 | 2017-07-31 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David Gearing | CHIEF SCIENTIFIC OFFICER | Buy | $37K | 2016-03-03 |
| Geraldine T. Farrell | VP Operations & General Counsel | Sell | $432 | 2016-03-03 |
| Ashraf Hanna | Director | Buy | $5K | 2016-03-02 |
| David Gearing | Chief Scientific Officer | Buy | $103K | 2016-02-25 |
| Cormac G. Kilty | Director | Buy | $10K | 2016-02-24 |
| David T. Kim | 10% | Buy | $1.4M |
Companies that share insiders with NVET, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2016-02-24 |
| Damian T. Lismore | CFO | Buy | $16K | 2016-02-18 |
| George W. Gunn | Director | Buy | $55K | 2015-09-09 |
| Cormac G. Kilty | Director | Buy | $48K | 2015-09-09 |
| Richard B. Fried | 10% | Buy | $72K | 2015-09-09 |
| Funds Management Ltd Atf Asia Pacific Healthcare Fund One II | 10% | Buy | $1.0M | 2015-02-10 |
| Robert Atchinson | 10% | Buy | $2.8M | 2014-02-10 |